Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly vitamin D in deficient women with PCOS
2016-000503-87Phase 3Completed
- Sponsor
- Pharma Patent
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in polycystic ovary syndrome (PCOS) and Vitamin D deficiency (VDD) comparing Colecalciferol 30,000 IU weekly with Placebo (2 arms). Primary endpoint: Primary: Restoration of ovarian function. Started May 2016; status: completed.
02
Drugs
cholecalciferol
03
Conditions
polycystic ovary syndrome (PCOS)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on 2016-000503-87.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000503-87.